B-Complex: A Nutraceutical SANS Countermeasure — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

B-Complex: A Nutraceutical SANS Countermeasure — Stella

Recruiting

Back to Optic Disc Edema trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Johnson Space Center, Houston, Texas

Key details

Phase

Early testing

Sponsor

National Aeronautics and Space Administration (NASA)

Collaborators

Mayo Clinic, Texas A&M University

Enrollment target

~16 participants

Started

August 2022

Primary completion

July 2027

Age range

20 Years – 100 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov